CoChat

The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?

Open access
White, Edward, Read, John, Julo, Sherry · 2021 · Therapeutic Advances in Psychopharmacology

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 11 of the 72 sources its claims cite were checked for support.

Abstract

Background: Antidepressant withdrawal is experienced by about half of people who try to reduce or come off their medication. It can be a debilitating, long lasting process. Many clinicians misdiagnose or minimise symptoms, inadvertently prolonging suffering. Most are unable to help patients safely taper off. There has been little research into the peer support communities that are playing an increasingly important role in helping people withdraw from psychiatric medications. Methods: To illustrate the growth and activities of Facebook withdrawal groups, we examined 13 such groups. All were raising awareness of, and supporting individuals tapering off, antidepressants and were followed for 13 months. A further three groups were added for the last 5 months of the study. Results: In June 2020, the groups had a total membership of 67,125, of which, 60,261 were in private groups. The increase in membership for the 13 groups over the study period was 28.4%. One group was examined in greater detail. Group membership was 82.5% female, as were 80% of the Administrators and Moderators, all of whom are lay volunteers. Membership was international but dominated (51.2%) by the United States (US). The most common reason for seeking out this group was failed clinician-led tapers. Discussion: The results are discussed in the context of research on the prevalence, duration and severity of antidepressant withdrawal. We question why so many patients seek help in peer-led Facebook groups, rather than relying on the clinicians that prescribed the medications. The withdrawal experiences of tens of thousands of people remain hidden in these groups where they receive support to taper when healthcare services should be responsible. Further research should focus on the methods of support and tapering protocols used in these groups to enable improved, more informed support by clinicians. Support from Governments and healthcare agencies is also needed, internationally, to address this issue.

Overview

CoChat Summary

TL;DR

This study maps 16 Facebook groups supporting antidepressant withdrawal, finding 67,125 members in June 2020 and rapid growth, with most members seeking help after failed clinician-led tapers. It argues these peer-led groups are filling a gap left by health services that often misdiagnose or inadequately manage withdrawal.

Key findings

  • Across 16 groups, total membership was 67,125 on 10 June 2020; 60,261 were in private groups. The 13 groups followed for 13 months grew 28.4%, while all 16 grew 7.2% between first and last sampling dates.
  • In detailed Group 1 (venlafaxine), membership was 82.5% female; 80% of Administrators and Moderators were female; 51.2% of members were from the US. Failed clinician-led tapers were the most common reason for joining, estimated at 80–90%.
  • Group 1 recorded 7,127 posts (daily mean 20 ± 6) and 103,670 comments (285 ± 91) in the year to 25 January 2020, with mean daily active members 1428 ± 212; 39% of applicants were declined in that year.
  • Duloxetine had the most group activity: five duloxetine groups had 34,852 members (three private: 30,412); sertraline was second (9,649 in two private groups) and venlafaxine third (8,290 in two private groups).

Methods

  • Searched Facebook for public/private groups using keywords such as antidepressants, withdrawal and support; included only groups with “withdrawal” in the name or description. Sampled 16 groups (13 private, 3 public); membership was observed on five dates for 13 groups and three dates for 3 groups; admin/mod and group age data were collected on 25 January 2020.
  • Detailed Group 1 used Facebook Group Insights for 25 January 2019–25 January 2020 plus owner records since 2013; extracted membership growth, posts/comments, age/sex, location and admin/mod activity, omitting personal identifiers. Ethics approval was from the University of East London (ETH1920-0260).
  • Analysis was descriptive: membership totals and growth rates, plus Pearson correlations between group size and growth and between country population and members.

Limitations

  • Stated: the data cannot estimate the incidence or severity of antidepressant withdrawal in the general patient population, nor the proportion of patients on antidepressants who find these groups; admin/mod numbers were observed once and may have changed; successful taperers may remain and boost membership; double counting across groups is possible.
  • Evident from the text: the sample is not exhaustive and likely underestimates total Facebook withdrawal support; selection required “withdrawal” in the group name/description and relied on Facebook search; only one group was examined in detail; gender data were incomplete because generic admin/mod accounts could not be classified.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/2045125320981174

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. The total membership of the studied Facebook groups between 5 May 2019 and 10 June 2020. Solid circles represent the total membership of Groups 1–4, 6–10 and 13–16 (13 groups, recorded on five dates) and solid squares are the total membership of all 16 groups (recorded on three dates).
Figure 1. The total membership of the studied Facebook groups between 5 May 2019 and 10 June 2020. Solid circles represent the total membership of Groups 1–4, 6–10 and 13–16 (13 groups, recorded on five dates) and solid squares are the total membership of all 16 groups (recorded on three dates).CC BY-NC · PubMed Central
Figure 2. Relationship between total group membership on 10 June 2020 and membership growth rate during the study period (5 May 2019–10 June 2020) where group membership growth was positive (n = 15).
Figure 2. Relationship between total group membership on 10 June 2020 and membership growth rate during the study period (5 May 2019–10 June 2020) where group membership growth was positive (n = 15).CC BY-NC · PubMed Central
Figure 3. Cumulative number of private group (n = 13) members per medication. Numbers above bars are the number of groups for each medication.
Figure 3. Cumulative number of private group (n = 13) members per medication. Numbers above bars are the number of groups for each medication.CC BY-NC · PubMed Central
Figure 4. Cumulative growth of membership in Group 1, effexor (venlafaxine) side effects, withdrawal and discontinuation syndrome since group inception in November 2013.
Figure 4. Cumulative growth of membership in Group 1, effexor (venlafaxine) side effects, withdrawal and discontinuation syndrome since group inception in November 2013.CC BY-NC · PubMed Central
Figure 5. Percentage of male and female members in Group 1 by age range (years) and sex in June 2020; n = 6162.
Figure 5. Percentage of male and female members in Group 1 by age range (years) and sex in June 2020; n = 6162.CC BY-NC · PubMed Central
Figure 6. Country distribution of Group 1 members where country membership is greater than 20. Recorded on 29 January 2020.
Figure 6. Country distribution of Group 1 members where country membership is greater than 20. Recorded on 29 January 2020.CC BY-NC · PubMed Central

Verification

Claims the paper makes

5 Valid · 5 Not valid · 31 Not checked · 108 Own results and interpretations

55 more claims

Create a free account to see all 149 claims and to verify the 61 references still open.

See all claims — free account
  • Probably not a substantial claim. 70
  • It may state two separate claims as one. 33
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 53 references

Research works printed but not linked: 4

  1. Witt-Doerring J Shorter D Kosten M. Online communities for drug withdrawal: what can we learn? Psychiatr Times 2018; 35: 4.
  2. Davies J Pauli R Montagu L. A survey of antidepressant withdrawal reactions and their management in primary care. All Party Parliamentary Group for Prescribed Drug Dependence, 2018.
  3. Horowitz M. Antidepressant withdrawal syndrome and its management. London: Royal College of Psychiatrists, 2019.
  4. Young A Currie A. Physicians’ knowledge of antidepressant withdrawal effects: a survey. J Clin Psychiatry 1997; 58: 28– 30. 9219491

Cited by

See all 75

Metadata

Authors
White, E., Read, J., & Julo, S.
Affiliations
  • Independent Researcher, Knapp House, 66 North Street, Pewsey, SN95NX UK
  • University of East London (GB)
  • Kansas City, MO, USA
Corresponding author
Read, John
Venue
Therapeutic Advances in Psychopharmacology
Published
2021-01
Volume
11
Pages
2045125320981174-2045125320981174
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W3112695252
Cited by
63
References
52
Citations by year
2026: 6 · 2025: 5 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 9
FWCI
14.61
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UEL Research Repository (University of East London) (submittedVersion)
Topics
  • Health Sciences › Health Professions › General Health Professions › Health Literacy and Information Accessibility
  • Social Sciences › Health › Social Media in Health Education
  • Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
Keywords
antidepressant discontinuation, Facebook groups, social media, peer support, medication tapering, online communities, lay volunteers, patient awareness, mental health services

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? https://app.cochat.ai/papers/10.1177/2045125320981174
The paper
White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services? Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320981174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.